Another thing, independent of personalities. Theranos was well-funded. It built prototypes. Its engineering case was, “You can get sufficiently good testing S/N ratio with much, much smaller blood samples.” They couldn’t. Period. It remains an unsolved problem, just like stick-free blood sugar testing, which has consumed more than $1B of funding, I believe.